Thus, we conducted quantitative assessments of the immunoexpression levels of CSC markers, including ALDH1, CD44, p75NTR, and BMI-1, along with E-cadherin, in both OSCC primary tumours and metastatic lymph nodes through the utilization of IHC. The gene discussed is CD44; the disease is neoplasm.